7-Amino-3-hydroxy-1-indanone
|
- $343 - $1023
- Product name: 7-Amino-3-hydroxy-1-indanone
- CAS: 352000-78-3
- MF: C9H9NO2
- MW: 163.17
- EINECS:
- MDL Number:MFCD12827809
- Synonyms:7-Amino-3-hydroxy-1-indanone;7-Amino-3-hydroxy-2,3-dihydro-1H-inden-1-one;1H-Inden-1-one, 7-amino-2,3-dihydro-3-hydroxy-
4 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
Package
- 250mg
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number1288AE
- Product description7-Amino-3-hydroxy-1-indanone
- Packaging500mg
- Price$1023
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12080042
- Product description7-Amino-3-hydroxy-2,3-dihydro-1H-inden-1-one 95+%
- Packaging1g
- Price$858
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12080042
- Product description7-Amino-3-hydroxy-2,3-dihydro-1H-inden-1-one 95+%
- Packaging250mg
- Price$343
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number048498
- Product description7-Amino-3-hydroxy-1-indanone >95%
- Packaging500mg
- Price$721
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 1288AE | 7-Amino-3-hydroxy-1-indanone | 500mg | $1023 | 2021-12-16 | Buy |
| Crysdot | CD12080042 | 7-Amino-3-hydroxy-2,3-dihydro-1H-inden-1-one 95+% | 1g | $858 | 2021-12-16 | Buy |
| Crysdot | CD12080042 | 7-Amino-3-hydroxy-2,3-dihydro-1H-inden-1-one 95+% | 250mg | $343 | 2021-12-16 | Buy |
| Matrix Scientific | 048498 | 7-Amino-3-hydroxy-1-indanone >95% | 500mg | $721 | 2021-12-16 | Buy |
Properties
Melting point :116-118°
Boiling point :377.5±42.0 °C(Predicted)
Density :1.427±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :13.30±0.20(Predicted)
Boiling point :377.5±42.0 °C(Predicted)
Density :1.427±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :13.30±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|